News
-
-
PRESS RELEASE
Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund
Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment -
-
PRESS RELEASE
Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors -
-
-
-
PRESS RELEASE
Andera Partners and Bpifrance co-lead €27 million Series B round for EG 427 to finance ongoing clinical study and platform development
Andera Partners and Bpifrance co-lead €27 million Series B round for EG 427 to finance ongoing clinical study and platform development in the field of neuro-urology. Proceeds will advance genetic medicine solutions using HERMES vector technology -
-
PRESS RELEASE
New York Life Investments and its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners
New York Life Investments and Candriam partner with Andera Partners to expand global alternatives offering. AUM growth and strategic opportunities envisioned by the partnership
